D-1134-2017 Class III Terminated

Recalled by Ascend Laboratories LLC — Montvale, NJ

FDA drug recall D-1134-2017 was initiated by Ascend Laboratories LLC on May 5, 2017 and is designated Class III. Reason for recall: PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg. The recall status is terminated (terminated Apr 25, 2018). Affected quantity: 1212 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 20, 2017
Initiation Date
May 5, 2017
Termination Date
Apr 25, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1212 bottles

Product description

AMLODIPINE BESYLATE TABLET, USP, 10 mg, 1000 count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC Montvale, NJ 07645, NDC 67877-199-10

Reason for recall

PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg.

Distribution pattern

Nationwide in the USA.

Code information

Lot #: 6142626, Exp 09/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1134-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1134-2017. Report a data issue: hello@regdatalab.com.